Skip to content

Study note

Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducible.

PMID 32497061 (2020): taper — Time-trial performance (study note for endurance athletes).

Updated Jul 22, 2026

Read the study note

Study note • PMID 32497061

Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducible.

PloS one2020 • DOI 10.1371/journal.pone.0234027

How to use this page

This note summarizes one study record. Check the participants, methods, results, and limitations before applying it to training.

  • Design signal: cohort study.
  • Population relevance: athlete/trained context.
  • Consistency: single-study evidence.
  • Practical recommendation depends on tolerance, context, and whether it protects training consistency.

ELI5

In plain language

INTRODUCTION: We repeated our study of intensified training on a ketogenic low-carbohydrate (CHO), high-fat diet (LCHF) in world-class endurance athletes, with further investigation of a "carryover" effect on performance… (cohort study; n=8 elite athletes).

The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: INTRODUCTION: We repeated our study of intensified training on a ketogenic low-carbohydrate (CHO), high-fat diet (LCHF) in world-class endurance athletes, with further investigation of a "carryover" effect on performance…
  • The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions.
  • Population: n=8 elite athletes.
  • Protocol cues (title/abstract): 000 m • 20 km.

Protocol

Protocol (as reported)

  • Intervention/exposure: taper.
  • Dose/time/duration cues in abstract/title: 000 m • 20 km.
  • Outcomes: Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it may help, and who should be cautious

Who it helps

  • Athletes similar to the study population (n=8 elite athletes) working on tapering.
  • Athletes who can measure Time-trial performance with a repeatable workout or time-trial effort.

Who should be cautious

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: cohort study.
  • Population: n=8 elite athletes.
  • Outcomes measured: Time-trial performance.
  • Protocol cues mentioned: 000 m • 20 km.
  • Source: PubMed PMID 32497061 (2020) — PloS one.

Results excerpt

What the abstract reports

All groups increased VO2peak (ml∙kg-1∙min-1) at Adapt (p = 0.02, 95%CI: [0.35-2.74]).

Note: excerpts are short; for full context, read the paper.

Limits

Limitations and bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Adaptive AI coach for iPhone

Meet your adaptive AI coach.

Tell your coach what you are training for. It builds the plan, follows the work you complete, and adapts upcoming training when recovery, your schedule, or real life changes.

Keep going

Sources